Locus-specific and activity-independent gene repositioning during ...
To further probe if the gene repositioning events were related to underlying chromosome movements, the positions of selected whole chromosomes were ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
Drug Repositioning and Selection Program
Repositioning and Selection and gADME are trademarks of Gene Logic. All other trademarks are the property of their respective owners. ...
http://www.genelogic.com/docs/pdfs/DRS_Brochure.pdf...
|
Actin-dependent intranuclear repositioning of an active gene locus ...
Actin-dependent intranuclear repositioning of an active gene locus in vivo. Miroslav Dundr,1 Jason K. Ospina,2 Myong-Hee Sung,3 Sam John,3 Madhvi Upender,4
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...
|
Transcriptional repression mediated by repositioning of genes to ...
We devised an approach for inducible tethering of genes to the inner nuclear membrane (INM), and tested the consequences of such repositioning on gene ...
http://www.nature.com/nature/journal/v452/n7184/full/nature0...
|
Gene Logic Drug Repositioning Partnerships
Gene Logic's Drug Repositioning Partnership (Phase R™ Program) begins upon our receipt of your failed, stalled or deprioritized drug candidates. ...
http://www.genelogic.com/drugrepositioning/partnerships/drug...
|
Gene regulation: Repositioning tunes expression : Article : Nature ...
24 Apr 2008 ... Our view of gene regulation is increasingly three-dimensional — studies in the past few years suggest that repositioning of loci within the ...
http://www.nature.com/nrg/journal/v9/n5/full/nrg2377.html...
|
Silencing and Nuclear Repositioning of the lambda5 Gene Locus at ...
Strikingly, developmentally regulated nuclear repositioning of the lambda5 gene is impaired in pre-B cells lacking OBF-1 and Aiolos. ...
http://www.ncbi.nlm.nih.gov/pubmed/18974788?dopt=Abstract...
|
Gene Logic CEO: New Investment in Drug Repositioning Won t ...
Gene Logic CEO Mark Gessler told BioInform last week that the company s recent move into drug repositioning -- in which it intends to find new indications ...
http://www.bioinform.com/issues/9_12/features/131606-1.html...
|
paths to market exclusivity
Gene Logic 2006 white paper, “The Value of Drug Repositioning: A Gene Logic Analysis.” Back to page 3. 2. Gene Logic 2006 white paper. Back to page 3 ...
http://www.genelogic.com/PhaseR/docs/DrugRepositioning_04.pd...
|
Gene Logic Sells Informatics Business to Ocimum, Pins Future on ...
To focus on drug repositioning and development, Gene Logic has sold its genomics arm to India’s Ocimum Biosystems for $10 million. ...
http://www.bioinform.com/issues/11_40/features/142849-1.html...
|
